Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 4/14/25: How Deep Will Medicaid Cuts Go? Resonating with Younger Demographics & more

ByMiranda Schmalfuhs

April 14th 2025

Pharma Pulse 4/11/25: Long-Term Sustainability for Diverse Trial Initiatives, Payers Consider Policy Options for GLP-1 Access & more

ByMiranda Schmalfuhs

April 11th 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/10/25: Treating Chronic Cough with Digital Therapeutics, ADHD Stimulants Have Minimal Effect on Cardiovascular System & more

ByMiranda Schmalfuhs

April 10th 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/9/25: Effectively Cutting Through the Misinformation Noise, Addressing Drug Shortages & more

ByMiranda Schmalfuhs

April 9th 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/8/25: Banks Postpone Loans as Tariffs Stoke Fears, GLP-1 and Biosimilars Trends & more

ByMiranda Schmalfuhs

April 8th 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/7/25: Advancements for Future Pandemic Preparedness and Supply Chain Stability, Microbial Preservation Supports Quality and Safety in Compounding Pharmacies & more

ByMiranda Schmalfuhs

April 7th 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/4/25: The ‘Healthy Immigrant Effect’, Google Gemini, AI Commercialization in Pharma & more

ByMiranda Schmalfuhs

April 4th 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/3/25: Analyzing the Theranos Appeals, Current CAR-T Therapy Trends in Managed Care & more

ByMiranda Schmalfuhs

April 3rd 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/2/25: Balancing Cost-Efficiency with Domestic Manufacturing Need, Making M3P Work for Your Pharmacy & more

ByMiranda Schmalfuhs

April 2nd 2025

The latest news for pharma industry insiders.

Pharma Pulse 4/1/25: Restructuring Medical Device Supply Chains, Role of Pharmacists in COVID-19 Care and Prevention & more

ByMiranda Schmalfuhs

April 1st 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/31/25: Bridging the HCP-Patient Divide, Kennedy Proposes Massive Reorganization, Staff Cuts at HHS & more

ByMiranda Schmalfuhs

March 31st 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/28/25: Medicare Costs Rise in 2025, How Improving Financial Management Directly Impacts Drug Pricing & more

ByMiranda Schmalfuhs

March 28th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/27/25: Ethical Considerations for AI Use in Medication Access, The Future of PBMs in 2025 & more

ByMiranda Schmalfuhs

March 27th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/26/25: Balancing Technological & Human Support in Medication Access, How PBMs’ Vertical Integration Impacts Health Care & more

ByMiranda Schmalfuhs

March 26th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/25/25: Identifying Affordability Issues with Predictive Analytics, Novo Nordisk Extends Lowered Wegovy Price to Retail Pharmacies & more

ByMiranda Schmalfuhs

March 25th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/24/25: Strategies to Address Rising Medication Costs, Optum Rx Changes How Pharmacies Are Reimbursed & more

ByMiranda Schmalfuhs

March 24th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/21/25: The Biggest Bottlenecks for Patients, Age and Comorbidities Drive RSV Hospitalization Rates & more

ByMiranda Schmalfuhs

March 21st 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/20/25: New Ways of Targeting Cancer, How Employers Can Support Employee Well-Being and Mental Health & more

ByMiranda Schmalfuhs

March 20th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/19/25: Strategies to Close Women’s Health Innovation Gap, Enhancing Patient Care in Heart Failure–Related Anemia & more

ByMiranda Schmalfuhs

March 19th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/18/25: Causes of the Innovation Gap in Women’s Health, FDA Grants Kerendia Priority Review in Heart Failure & more

ByMiranda Schmalfuhs

March 18th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/17/25: Dual Trial Strategies, Executive Order Advances Price Transparency Efforts & more

ByMiranda Schmalfuhs

March 17th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/14/25: Pre-Launch Prep for Emerging Biopharmas, Using the Power of Three to Simplify the Business of Healthcare & more

ByMiranda Schmalfuhs

March 14th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/13/25: Trends Shaping Direct to Patient in Pharma, Empowering Pharmacies to Add New Sustainable Care Services & more

ByMiranda Schmalfuhs

March 13th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/12/25: Navigating Public Health in the Digital Age, Americans Give Healthcare a 'C' Grade & more

ByMiranda Schmalfuhs

March 12th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/11/25: Integrated Multi-Omic Data, What’s Changed and What Hasn’t Following the COVID-19 Pandemic & more

ByMiranda Schmalfuhs

March 11th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/10/25: NIH’s Role in New Drug Development, Future Directions in Biosimilar Health Care Delivery & more

ByMiranda Schmalfuhs

March 10th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/7/25: Shaping Trust Through Design, New Interest in Direct Contracting & more

ByMiranda Schmalfuhs

March 7th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/6/25: Regulatory Agencies Role in Battle Against Misinformation, Developing Winning Supplemental Benefits Packages & more

ByMiranda Schmalfuhs

March 6th 2025

Pharma Pulse 3/5/25: Tariff Impact on Medication Availability/Accessibility for Telehealth Patients, Addressing the Gap in Type 1 Diabetes Care & more

ByMiranda Schmalfuhs

March 5th 2025

The latest news for pharma industry insiders.

Pharma Pulse 3/4/25: How to Mitigate a Potential Drop in Demand Due to Tariffs, What ‘Going Wild’ on Healthcare Could Mean & more

ByMiranda Schmalfuhs

March 4th 2025

The latest news for pharma industry insiders.

Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 4/14/25: How Deep Will Medicaid Cuts Go? Resonating with Younger Demographics & more

Pharma Pulse 4/11/25: Long-Term Sustainability for Diverse Trial Initiatives, Payers Consider Policy Options for GLP-1 Access & more

Pharma Pulse 4/10/25: Treating Chronic Cough with Digital Therapeutics, ADHD Stimulants Have Minimal Effect on Cardiovascular System & more

Pharma Pulse 4/9/25: Effectively Cutting Through the Misinformation Noise, Addressing Drug Shortages & more

Pharma Pulse 4/8/25: Banks Postpone Loans as Tariffs Stoke Fears, GLP-1 and Biosimilars Trends & more

Pharma Pulse 4/7/25: Advancements for Future Pandemic Preparedness and Supply Chain Stability, Microbial Preservation Supports Quality and Safety in Compounding Pharmacies & more

Pharma Pulse 4/4/25: The ‘Healthy Immigrant Effect’, Google Gemini, AI Commercialization in Pharma & more

Pharma Pulse 4/3/25: Analyzing the Theranos Appeals, Current CAR-T Therapy Trends in Managed Care & more

Pharma Pulse 4/2/25: Balancing Cost-Efficiency with Domestic Manufacturing Need, Making M3P Work for Your Pharmacy & more

Pharma Pulse 4/1/25: Restructuring Medical Device Supply Chains, Role of Pharmacists in COVID-19 Care and Prevention & more

Pharma Pulse 3/31/25: Bridging the HCP-Patient Divide, Kennedy Proposes Massive Reorganization, Staff Cuts at HHS & more

Pharma Pulse 3/28/25: Medicare Costs Rise in 2025, How Improving Financial Management Directly Impacts Drug Pricing & more

Pharma Pulse 3/27/25: Ethical Considerations for AI Use in Medication Access, The Future of PBMs in 2025 & more

Pharma Pulse 3/26/25: Balancing Technological & Human Support in Medication Access, How PBMs’ Vertical Integration Impacts Health Care & more

Pharma Pulse 3/25/25: Identifying Affordability Issues with Predictive Analytics, Novo Nordisk Extends Lowered Wegovy Price to Retail Pharmacies & more

Pharma Pulse 3/24/25: Strategies to Address Rising Medication Costs, Optum Rx Changes How Pharmacies Are Reimbursed & more

Pharma Pulse 3/21/25: The Biggest Bottlenecks for Patients, Age and Comorbidities Drive RSV Hospitalization Rates & more

Pharma Pulse 3/20/25: New Ways of Targeting Cancer, How Employers Can Support Employee Well-Being and Mental Health & more

Pharma Pulse 3/19/25: Strategies to Close Women’s Health Innovation Gap, Enhancing Patient Care in Heart Failure–Related Anemia & more

Pharma Pulse 3/18/25: Causes of the Innovation Gap in Women’s Health, FDA Grants Kerendia Priority Review in Heart Failure & more

Pharma Pulse 3/17/25: Dual Trial Strategies, Executive Order Advances Price Transparency Efforts & more

Pharma Pulse 3/14/25: Pre-Launch Prep for Emerging Biopharmas, Using the Power of Three to Simplify the Business of Healthcare & more

Pharma Pulse 3/13/25: Trends Shaping Direct to Patient in Pharma, Empowering Pharmacies to Add New Sustainable Care Services & more

Pharma Pulse 3/12/25: Navigating Public Health in the Digital Age, Americans Give Healthcare a 'C' Grade & more

Pharma Pulse 3/11/25: Integrated Multi-Omic Data, What’s Changed and What Hasn’t Following the COVID-19 Pandemic & more

Pharma Pulse 3/10/25: NIH’s Role in New Drug Development, Future Directions in Biosimilar Health Care Delivery & more

Pharma Pulse 3/7/25: Shaping Trust Through Design, New Interest in Direct Contracting & more

Pharma Pulse 3/6/25: Regulatory Agencies Role in Battle Against Misinformation, Developing Winning Supplemental Benefits Packages & more

Pharma Pulse 3/5/25: Tariff Impact on Medication Availability/Accessibility for Telehealth Patients, Addressing the Gap in Type 1 Diabetes Care & more

Pharma Pulse 3/4/25: How to Mitigate a Potential Drop in Demand Due to Tariffs, What ‘Going Wild’ on Healthcare Could Mean & more

Latest Updated Articles

Trending on Pharmaceutical Commerce

Why UPS Committed $48M to Cold-Chain Cross-Dock Buildout

Payers Want Real-World Evidence. Why Aren't They Using It?

Philip Sclafani: Will PBM Reform Actually Lower Net Drug Costs?

How the US Section 301 Probe Targets Germany's Drug Pricing

How GLP-1 Growth and Specialty Drugs Are Driving Cost Pressure